Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species
An enavogliflozin ophthalmic solution (DWRX2008) is being developed to treat diabetic retinopathy and macular edema. This study evaluated the ocular distribution and plasma pharmacokinetics (PKs) of enavogliflozin in animal species. A sample of [<sup>14</sup>C] enavogliflozin was ocularl...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
MDPI AG
2024-01-01
|
| Serie: | Pharmaceuticals |
| Ämnen: | |
| Länkar: | https://www.mdpi.com/1424-8247/17/1/111 |